Advertisement

Mood Stabilizers During Lactation

  • Sandeep Grover
  • Devakshi Dua
Chapter

Abstract

Bipolar disorder usually starts at a very early age, and due to this females suffering from this disorder are at risk of an episode throughout their reproductive life. Data also suggest the association of relapse and recurrence of episodes in females with bipolar disorder, during pregnancy and postpartum. Some of the postpartum-onset psychiatric syndromes also are known to turn out to be bipolar disorder in the long run. Due to all these factors, on many occasions, females with bipolar disorder have to be continued on mood stabilizers during pregnancy and lactation. Data on the safety of use of mood stabilizers during pregnancy and lactation is very limited and is of poor quality. Most of the data is available in the form of case reports, small case series or small sample open-label studies. Hence, clinicians are often faced with a situation, where they have to weigh the pros and cons of prescribing mood stabilizers during lactation. Further, clinicians are often faced with a situation whether to recommend breastfeeding for a neonate, whose mother is taking mood stabilizers. Considering the benefits of breastfeeding for both mother and the neonate, it can be suggested that, wherever feasible, breastfeeding must be continued. Available data suggest that compared to other mood stabilizers, valproate is a better option. If the mother is allowed to breastfeed while taking mood stabilizers, then certain physiological aspects of the newborn’s sleep must be taken into account. Medications can be taken after feeding the baby, just before the newborn’s longest sleep duration.

Keywords

Bipolar disorder Mood stabilizers Breastfeeding Lactation 

References

  1. 1.
    Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, Manber R, Viguera A, Suppes T, Altshuler L. Management of bipolar disorder during pregnancy and the postpartum period. Focus. 2005;3:266–79.CrossRefGoogle Scholar
  2. 2.
    Munk-Olsen T, Laursen TM, Meltzer-Brody S, Mortensen PB, Jones I. Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Arch Gen Psychiatry. 2012;69:428–34.CrossRefGoogle Scholar
  3. 3.
    Grover S, Avasthi A. Mood stabilizers in pregnancy and lactation. Indian J Psychiatry. 2015;57(Suppl 2):S308–23.CrossRefGoogle Scholar
  4. 4.
    Smith B, Dubovsky SL. Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women. Expert Opin Pharmacother. 2017;18:1703–19.CrossRefGoogle Scholar
  5. 5.
    Freeman MP, Smith KW, Freeman SA, McElroy SL, Kmetz GE, Wright R, Keck PE Jr. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63:284–7.CrossRefGoogle Scholar
  6. 6.
    Jones I, Craddock N. Bipolar disorder and childbirth: the importance of recognising risk. Br J Psychiatry. 2005;186:453–4.CrossRefGoogle Scholar
  7. 7.
    Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007b;164:1817–24.CrossRefGoogle Scholar
  8. 8.
    Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987;150:662–73.CrossRefGoogle Scholar
  9. 9.
    Terp IM, Mortensen PB. Post-partum psychoses. Clinical diagnoses and relative risk of admission after parturition. Br J Psychiatry. 1998;172:521–6.CrossRefGoogle Scholar
  10. 10.
    Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000;157:179–84.CrossRefGoogle Scholar
  11. 11.
    Jefferson JW, Greist J, Ackermann D. Lithium encyclopaedia for clinical practice. 2nd ed. Washington, DC: American Psychiatric Press; 1987. p. 504–25.Google Scholar
  12. 12.
    Britton JR, Britton HL, Gronwaldt V. Breastfeeding, sensitivity, and attachment. Pediatrics. 2006;118:1436–43.CrossRefGoogle Scholar
  13. 13.
    Department of Health and Human Service Office on Women’s Health. Benefits of breastfeeding. Nutr Clin Care. 2003;6:125–31.Google Scholar
  14. 14.
    Horta BL, de Sousa BA, de Mola CL. Breastfeeding and neurodevelopmental outcomes. Curr Opin Clin Nutr Metab Care. 2018;21:112–5.Google Scholar
  15. 15.
    Gartner LM, Morton J, Lawrence RA, Naylor AJ, O’Hare D, Schanler RJ, Eidelman AI, American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496–506.CrossRefGoogle Scholar
  16. 16.
    Lawrence RM. Circumstances when breastfeeding is contraindicated. Pediatr Clin N Am. 2013;60:295–318.CrossRefGoogle Scholar
  17. 17.
    Burt VK, Suri R, Altshuler L, Stowe Z, Hendrick VC, Muntean E. The use of psychotropic medications during breast-feeding. Am J Psychiatry. 2001;158:1001–9.CrossRefGoogle Scholar
  18. 18.
    Ito S, Lee A. Drug excretion into breast milk—overview. Adv Drug Deliv Rev. 2003;55:617–27.CrossRefGoogle Scholar
  19. 19.
    Beath SV. Hepatic function and physiology in the newborn. Semin Neonatol. 2003;8:337–46.CrossRefGoogle Scholar
  20. 20.
    Bogen DL, Sit D, Genovese A, Wisner KL. Three cases of lithium exposure and exclusive breastfeeding. Arch Womens Ment Health. 2012;15:69–72.CrossRefGoogle Scholar
  21. 21.
    Moretti ME, Koren G, Verjee Z, Ito S. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. Ther Drug Monit. 2003;25:364–6.CrossRefGoogle Scholar
  22. 22.
    Frew JR. Psychopharmacology of bipolar I disorder during lactation: a case report of the use of lithium and aripiprazole in a nursing mother. Arch Womens Ment Health. 2015;18:135–6.CrossRefGoogle Scholar
  23. 23.
    Viguera AC, Newport DJ, Ritchie J, Stowe Z, Whitfield T, Mogielnicki J, Baldessarini RJ, Zurick A, Cohen LS. Lithium in breast milk and nursing infants: clinical implications. Am J Psychiatry. 2007a;164:342–5.CrossRefGoogle Scholar
  24. 24.
    Piontek CM, Baab S, Peindl KS, Wisner KL. Serum valproate levels in 6 breastfeeding mother-infant pairs. J Clin Psychiatry. 2000;61:170–2.CrossRefGoogle Scholar
  25. 25.
    Wisner KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Clin Psychopharmacol. 1998;18:167–9.CrossRefGoogle Scholar
  26. 26.
    Harden CL, Hopp J, Ting TY, Pennell PB, French JA, Allen Hauser W, Wiebe S, Gronseth GS, Thurman D, Meador KJ, Koppel BS, Kaplan PW, Robinson JN, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Le Guen C, American Academy of Neurology; American Epilepsy Society. Management issues for women with epilepsy-focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009;50:1229–36.CrossRefGoogle Scholar
  27. 27.
    Sachs HC, Drugs CO. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. Pediatrics. 2013;132:e796–809.CrossRefGoogle Scholar
  28. 28.
    Stahl MM, Neiderud J, Vinge E. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr. 1997;130:1001–3.CrossRefGoogle Scholar
  29. 29.
    Chaudron LH, Jefferson JW. Mood stabilizers during breastfeeding: a review. J Clin Psychiatry. 2000;61:79–90.CrossRefGoogle Scholar
  30. 30.
    Frey B, Schubiger G, Musy JP. Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur J Pediatr. 1990;150:136–8.CrossRefGoogle Scholar
  31. 31.
    Merlob P, Mor N, Litwin A. Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacother. 1992;26:1563–5.CrossRefGoogle Scholar
  32. 32.
    Lutz UC, Wiatr G, Gaertner H-J, Bartels M. Oxcarbazepine treatment during breast-feeding: a case report. J Clin Psychopharmacol. 2007;27:730–2.CrossRefGoogle Scholar
  33. 33.
    Liporace J, Kao A, D’Abreu A. Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav. 2004;5:102–5.CrossRefGoogle Scholar
  34. 34.
    Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia. 2000;41:709–13.CrossRefGoogle Scholar
  35. 35.
    Page-Sharp M, Kristensen JH, Hackett LP, Beran RG, Rampono J, Hale TW, Kohan R, Ilett KF. Transfer of lamotrigine into breast milk. Ann Pharmacother. 2006;40:1470–1.CrossRefGoogle Scholar
  36. 36.
    Rambeck B, Kurlemann G, Stodieck SR, May TW, Jürgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol. 1997;51:481–4.CrossRefGoogle Scholar
  37. 37.
    Newport DJ, Pennell PB, Calamaras MR, Ritchie JC, Newman M, Knight B, Viguera AC, Liporace J, Stowe ZN. Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics. 2008;122:e223–31.CrossRefGoogle Scholar
  38. 38.
    Nordmo E, Aronsen L, Wasland K, Småbrekke L, Vorren S. Severe apnea in an infant exposed to lamotrigine in breast milk. Ann Pharmacother. 2009;43:1893–7.CrossRefGoogle Scholar
  39. 39.
    Ohman I, Vitols S, Luef G, Söderfeldt B, Tomson T. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia. 2002;43:1157–60.CrossRefGoogle Scholar
  40. 40.
    Gentile S. Topiramate in pregnancy and breastfeeding. Clin Drug Investig. 2009;29:139–41.CrossRefGoogle Scholar
  41. 41.
    Westergren T, Hjelmeland K, Kristoffersen B, Johannessen SI, Kalikstad B. Probable topiramate-induced diarrhea in a 2-month-old breast-fed child – a case report. Epilepsy Behav Case Rep. 2014;2:22–3.CrossRefGoogle Scholar
  42. 42.
    Ohman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia. 2005;46:1621–4.CrossRefGoogle Scholar
  43. 43.
    Kristensen JH, Ilett KF, Hackett LP, Kohan R. Gabapentin and breastfeeding: a case report. J Hum Lact. 2006;22:426–8.CrossRefGoogle Scholar
  44. 44.
    Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry. 1995;152:1641–5.CrossRefGoogle Scholar
  45. 45.
    Davanzo R, Dal Bo S, Bua J, Copertino M, Zanelli E, Matarazzo L. Antiepileptic drugs and breastfeeding. Ital J Pediatr. 2013;39:50–4.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Sandeep Grover
    • 1
  • Devakshi Dua
    • 1
  1. 1.Department of PsychiatryPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations